000 01483 a2200445 4500
005 20250517053132.0
264 0 _c20160902
008 201609s 0 0 eng d
022 _a1539-2864
024 7 _a10.1097/IAE.0000000000000760
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDay, Shelley
245 0 0 _aINTRAVITREAL SULFUR HEXAFLUORIDE INJECTION FOR THE TREATMENT OF VITREOMACULAR TRACTION SYNDROME.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_cApr 2016
300 _a733-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIntravitreal Injections
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetinal Diseases
_xdiagnosis
650 0 4 _aRetrospective Studies
650 0 4 _aSulfur Hexafluoride
_xadministration & dosage
650 0 4 _aTissue Adhesions
650 0 4 _aTomography, Optical Coherence
650 0 4 _aVision Disorders
_xphysiopathology
650 0 4 _aVisual Acuity
_xdrug effects
650 0 4 _aVitreous Detachment
_xdiagnosis
700 1 _aMartinez, Jose A
700 1 _aNixon, Peter A
700 1 _aLevitan, Mark
700 1 _aDooner, James W
700 1 _aWong, Robert W
700 1 _aHarper, Clio A
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 36
_gno. 4
_gp. 733-7
856 4 0 _uhttps://doi.org/10.1097/IAE.0000000000000760
_zAvailable from publisher's website
999 _c25274231
_d25274231